Latest Intestinal Ultrasound Advancements In Inflammatory Bowel Disease
Canadian IBD Today · 2024
DOI: 10.58931/cibdt.2024.2124 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian IBD Today, 2024. Verfasst von Cathy Lu. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) treatment has evolved from monitoring clinical symptoms to targeting objective measurements of mucosal healing with endoscopic and radiologic imaging. It is well known that clinical symptoms do not match disease severity. Frequent evaluation with radiologic imaging is now the standard of care. Although Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE-II) recommendations do not list radiographic targets as an endpoint due to the “limited ability of the currently available treatments to achieve transmural healing,” this will likely evolve over time particularly with the rapidly growing uptake of intestinal ultrasound (IUS) in clinical trials. For the time being, imaging is considered as an “adjuvant assessment rather than a formal treatment target.”
Zitieren
APA
Lu, C. (2024). Latest Intestinal Ultrasound Advancements In Inflammatory Bowel Disease. Canadian IBD Today. https://doi.org/10.58931/cibdt.2024.2124
Vancouver
Lu C. Latest Intestinal Ultrasound Advancements In Inflammatory Bowel Disease. Canadian IBD Today. 2024. doi:10.58931/cibdt.2024.2124
BibTeX
@article{Lu2024,
author = {Lu, Cathy},
title = {Latest Intestinal Ultrasound Advancements In Inflammatory Bowel Disease},
journal = {Canadian IBD Today},
year = {2024},
doi = {10.58931/cibdt.2024.2124}
}
EUVIMED